Aplikasi Sistem Informasi Ketersediaan Ruang Rawat dan Ketersediaan Darah (SIDARURAT) di Kabupaten Pekalongan

Kondisi yang mendesak misalnya gagal jantung, gagal nafas, perdarahan post partum, eklamsia atau kondisi yang mengancam nyawa lainya membuat tenaga kesehatan, pasien dan keluarga pasien sangat ingin segera mendapat informasi rumah sakit tentang ketersediaan ruang rawat dan ketersediaan darah. Teknologi yang diterapkan pada perangkat seluler dapat menjadi strategi penting dalam program penyediaan informasi ketersediaan ruang rawat dan ketersediaan darah. Penelitian ini bertujuan untuk membuat aplikasi ketersediaan ruang rawat dan ketersediaan darah (siDARURAT). Penelitian ini menggunakan desain penelitian Waterfall dengan uji black box.Hasil penelitian ini yaitu terbentuk aplikasi siDARURAT yang dapat digunakan melalui smartphone atau komputer, dan fungsi dalam sistem, baik form maupun tombol-tombol yang ada telah berjalan sesuai fungsinya berdasarkan pengujian black box. Agar aplikasi ini lebih maksimal, diharapkan rumah sakit dan PMI secara rutin mengupdate data ketersediaan ruang rawat dan ketersediaan darah.

Antidepressant Black Box Warning Draws Fire by Not Including Suicide Causality

Pediatric News ◽

10.1016/s0031-398x(05)70037-0 ◽

2005 ◽

Vol 39 (3) ◽

pp. 24

Author(s):

KATE JOHNSON

Keyword(s):

FDA: Contrast Agent Black Box Behind NSF Reduction

Skin & Allergy News ◽

10.1016/s0037-6337(10)70014-0 ◽

2010 ◽

Vol 41 (1) ◽

pp. 10

Author(s):

KERRI WACHTER

Keyword(s):

Contrast Agent ◽

FDA Adds Black Box Warning for Elidel, Protopic

10.1016/s1097-8690(05)70295-x ◽

2005 ◽

Vol 38 (7) ◽

pp. 49

Author(s):

DEEANNA FRANKLIN

Keyword(s):

Black Box for Elidel, Pimecrolimus Challenged

10.1016/s1097-8690(05)70648-x ◽

2005 ◽

Vol 38 (9) ◽

pp. 31

Author(s):

BETSY BATES

Keyword(s):

MI Warning Added to Rosiglitazone Black Box

10.1016/s1097-8690(07)71385-9 ◽

2007 ◽

Vol 40 (23) ◽

pp. 7

Author(s):

ELIZABETH MECHCATIE

Keyword(s):

Enbrel Gets Black Box For TB Risk

10.1016/s1097-8690(08)70436-0 ◽

2008 ◽

Vol 41 (8) ◽

pp. 4

Author(s):

BROOKE MCMANUS

Keyword(s):

Serum Vitamin B12 Concentrations among Mothers and Newborns and Follow-up Study to Assess Implication on the Growth Velocity and the Urinary Methylmalonic Acid Excretion

International Journal for Vitamin and Nutrition Research ◽

10.1024/0300-9831.79.56.297 ◽

2009 ◽

Vol 79 (56) ◽

pp. 297-307 ◽

Cited By ~ 3

Author(s):

Laila Hussein ◽

Sahar Abdel Aziz ◽

Salwa Tapouzada ◽

Boehles

Keyword(s):

Early Diagnosis ◽

Growth Velocity ◽

Methylmalonic Acid ◽

Post Partum ◽

Serum Vitamin ◽

Vitamin B ◽

Postnatal Life ◽

Negative Consequences ◽

Metabolic Marker ◽

Biochemical Measurement

Objective:Cobalamin (B12) deficiency has been reported in infants born to mothers with low cobalamin intake. Early diagnosis of vitamin B12 deficiency in infants is critical for the prevention of neurobehavioral disorders. We investigated the relationship between serum vitamin B12 level in newborns and in their healthy mothers who consumed an omnivorous diet. Anthropometry was studied longitudinally to assess the growth velocity of the infants. Urinary methylmalonic acid (MMA) excretion of 6-month old infants was compared retrospectively as the biomarker correlated with the initial serum vitamin B12 concentrations. Methods: Serum cobalamin and blood hemoglobin were determined in 84 pairs of newborns and their mothers. Urinary MMA excretion was measured in the same subjects during the first 6 months of the post partum period. Results: At birth, median serum cobalamin levels were 152.0 pmol/L in the mothers and 296.6 pmol/L in the newborns. Maternal and neonatal serum cobalamin levels had no effect on growth velocity during the first six months of postnatal life. Serum maternal and neonatal cobalamin levels were inversely associated with urinary MMA excretion. Conclusion: Early diagnosis of vitamin B12 status in neonates and infants is crucial, particularly in nutritionally deprived areas. Biochemical measurement of plasma cobalamin or its metabolic marker MMA is highly recommended. Urinary MMA measurement in cobalamin diagnostics provides an advantage in that blood sampling is not required. A vitamin B12 taskforce should be created to alleviate vitamin deficiency and its negative consequences.